Patient-driven Learning Lab to Improve Medication Safety during Care Transitions
Official title: Patient-Driven Medication Safety Learning Laboratory in Care Transitions
Funded at State University of New York at Buffalo · NIH-11414762 · Data updated 2026-11-12
A patient-facing program to understand and reduce medication harm for older adults during hospital transitions, by partnering with patients and caregivers and testing practical safety improvements.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project start | September 1, 2023 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $474,613 |
| NIH project number | 5R18HS029122-04 |
| Project ID | NIH-11414762 on NIH RePORTER |
Who could benefit from this research
✓Could help
Older adults taking multiple medications and their caregivers who experience or worry about medication changes during hospital transitions.
✕Less likely to help
Patients without upcoming transitions or without involvement in medication changes may not directly benefit.
What this research studies
This project builds a learning laboratory where patients, caregivers, and clinicians work together to map how medications are managed during care transitions. It uses a five-phase systems approach to analyze current safety gaps, design human-centered interventions, test them in simulated settings, and pilot them in real clinical care. The goal is to create scalable tools and practices that help older adults keep track of medicines and avoid adverse drug events as they move between hospital, home, and other care settings. End-users will be involved from the start to ensure solutions fit real-world needs. The work is conducted with patients and caregivers as key partners in every stage of development and testing.
Why it matters
Potential benefit: If successful, patients will have safer transitions of care and fewer medication-related harms.
How similar studies have gone: Previous work in medication safety during transitions has shown that patient-centered design can reduce errors and improve safety.
Where this research is happening
-
State University of New York at Buffalo
Amherst, United States Active
Researchers
- Principal investigator: Singh, Ranjit — State University of New York at Buffalo
- Study coordinator: Singh, Ranjit
Related research
Other NIH-funded projects on the same topics.
-
Improving population health by studying reproductive health and development.
This study is looking at how different factors, like the environment and genetics, affect the health of pregnant women and people of reproductive age, with the goal of improving pregnancy outcomes and the health of children as they grow up.
-
How noise and hearing loss affect the first step of hearing in the brain
This NIH grant studies how noise and conductive hearing loss change the intimate connections between auditory nerves and brain cells, which could influence how we hear in noisy environments.
-
Programmable hydrogels to protect transplanted human OPCs in demyelinating disease
Aims to improve survival and integration of transplanted human oligodendrocyte precursor cells by using specially designed hydrogels to reduce cell death during delivery in demyelinating diseases like multiple sclerosis.
-
How a mouth bacterium might fuel gum disease and heart risk
A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.
-
New dual-acting treatments against tough Klebsiella pneumoniae infections
A new funding opportunity aims to develop therapies that both fight and disarm the dangerous Klebsiella pneumoniae bacteria, especially strains that resist many drugs, to help patients with serious infections.
-
Muscle health and aging in postmenopausal women
This NIH grant supports a study in older, postmenopausal women to understand how insulin and blood sugar relate to muscle loss over time and whether this differs by race/ethnicity.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.